A pharmacotherapy review of the novel, oral antithrombotics

Area of Science:

• Cardiovascular Medicine
• Hematology
• Dental Pharmacology

Background:

• Coagulation disorders, including stroke and myocardial infarction, are leading causes of death in the U.S.
• Recent advancements have introduced novel agents for thromboembolism treatment and prevention.
• These newer anticoagulants, like warfarin, carry an increased risk of bleeding complications.

Purpose of the Study:

• To review emerging anticoagulant medications used for thromboembolism.
• To identify common side effects and drug interactions associated with these agents.
• To provide guidance for dental management of patients prescribed these newer anticoagulants.

Main Methods:

• Literature review of recent studies and clinical guidelines.
• Analysis of pharmacological profiles, indications, and adverse effects of newer anticoagulants.
• Examination of potential drug interactions relevant to dental procedures.

Main Results:

• Several new classes of anticoagulants are available, targeting different aspects of the coagulation cascade.
• Common side effects include bleeding, with specific interactions noted for certain agents.
• Understanding these medications is crucial for safe and effective dental treatment planning.

Conclusions:

• Newer anticoagulants offer alternatives for thromboembolism management but require careful consideration due to bleeding risks.
• Dental professionals must be aware of these agents to mitigate risks during treatment.
• Effective patient management involves understanding drug mechanisms, side effects, and interactions.